Page 3 - ஜோஷ் மெயில்மேன் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Napo EU S p A , Jaguar Health s Italian Subsidiary, Provides Updates on Plans to Pursue Conditional Marketing Authorization in the EU
theusnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theusnews.com Daily Mail and Mail on Sunday newspapers.
Jaguar Health & Dragon SPAC Announce Initial Funding of US$10 8 Million into Dragon SPAC
theusnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theusnews.com Daily Mail and Mail on Sunday newspapers.
Josh Mailman, co-founder, the Threshold Foundation, the Social Venture Network and Business for Social Responsibility, commenting on US author John Perkinsâ best seller, âConfessions of an Economic Hitmanâ wrote the following:
âA fascinating insiderâs view of how private multinational companies legally rob the poor of the Third World, country after countryâ¦â
John Perkins had worked for years as a consultant with an American company, MAINS, doing stints in Latin America and Asia. And his key function was to prepare development models for Third World countries that would ultimately benefit predatory corporate interests rather than the people it would claim to help.
(0)
Registration link for webcast interview appears below
SAN FRANCISCO, CA / ACCESSWIRE / April 21, 2021 / Jaguar Health, Inc. (NASDAQ:JAGX) ( Jaguar or the Company ) issued a reminder today about the
Innovators with Jane King interview of Lisa Conte, the Company s founder, president, and CEO, and Josh Mailman, the lead sponsor of the Dragon special purpose acquisition company (the Dragon SPAC ), that will air during a webcast this Friday, April 23, 2021, at 8:30 AM Eastern to provide a business overview of Napo EU S.p.A. ( Napo EU ), Jaguar s wholly owned Italian subsidiary.
Participation Instructions for Webcast
Participant Registration & Access Link:
Click Here
As announced, the Company is actively pursuing conditional marketing authorization from the European Medicines Agency for crofelemer for COVID-related diarrhea through Napo EU.
vimarsana © 2020. All Rights Reserved.